Notice of Intent to Sole Source Cytiva

Special NoticeNo Set AsideActive

Key Takeaways

  • Set-aside for No Set Aside businesses
  • Work to be performed in BETHESDA, MD
  • Industry: Software Publishers

Contract Details

Notice ID
26-001651
Opportunity Type
Special Notice
Sub-Agency
NATIONAL INSTITUTES OF HEALTH
Office
NATIONAL INSTITUTES OF HEALTH - CC
Posted Date
Thursday, March 19, 2026
Response Deadline
Thursday, March 26, 2026
PSC Code
6515
Set-Aside
No Set Aside
Place of Performance
BETHESDA, MD, 20892
Status
Active

Description

This acquisition is for SmartRedux Sepax 2 protocol software upgrade for the Sepax C-PRO equipment that will be used in manufacturing research and development of cell-based therapies for patients enrolled on NIH sponsored clinical trials at the National Institutes of Health (NIH) Clinical Center (CC). Product Service Code: 6515 Medical Instruments, Equipment, and Supplies NAICS Code: 512310 Software Publishers Place of Performance: Bethesda, MD 20892 USA POTS: 26-001651 Description: This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested. The National Institutes of Health (NIH) intends to award a fixed price purchase order to Global Life Sciences Solutions, on a firm fixed price sole source award basis to pr

Why This Opportunity Matters

HEALTH AND HUMAN SERVICES, DEPARTMENT OF is seeking responses for software publishers with a set-aside for No Set Aside businesses in BETHESDA, MD. This set-aside designation means eligible businesses face reduced competition from larger firms.